Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.

Yang Q, Ou C, Liu M, Xiao W, Wen C, Sun F.

Carcinogenesis. 2014 Jul;35(7):1643-51. doi: 10.1093/carcin/bgu084. Epub 2014 Apr 7.

PMID:
24710624
[PubMed - indexed for MEDLINE]
2.

EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.

Matsuda T, Takeuchi H, Matsuda S, Hiraiwa K, Miyasho T, Okamoto M, Kawasako K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S356-64. doi: 10.1245/s10434-014-3579-8. Epub 2014 Feb 25.

PMID:
24566863
[PubMed - indexed for MEDLINE]
3.

Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY.

Cancer Res. 2010 Nov 1;70(21):8832-41. doi: 10.1158/0008-5472.CAN-10-0779. Epub 2010 Oct 26.

PMID:
20978196
[PubMed - indexed for MEDLINE]
Free Article
4.

CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.

Lee KW, Sung CO, Kim JH, Kang M, Yoo HY, Kim HH, Um SH, Kim SH.

Int J Cancer. 2015 Jan 15;136(2):310-21. doi: 10.1002/ijc.29006. Epub 2014 Jun 26.

PMID:
24895167
[PubMed - indexed for MEDLINE]
5.

MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.

Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li M, Cao RS, Hao B, Zhang HJ, Qiu HQ, Shi RH.

Br J Cancer. 2014 Nov 11;111(10):2003-13. doi: 10.1038/bjc.2014.485. Epub 2014 Sep 11.

PMID:
25211657
[PubMed - indexed for MEDLINE]
6.

Lentivirus mediated GOLPH3 shRNA inhibits growth and metastasis of esophageal squamous cancer.

Wang Q, Wang X, Zhang CB.

Asian Pac J Cancer Prev. 2013;14(9):5391-6.

PMID:
24175832
[PubMed - indexed for MEDLINE]
Free Article
7.

Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.

Kwon J, Lee TS, Lee HW, Kang MC, Yoon HJ, Kim JH, Park JH.

Int J Oncol. 2013 Nov;43(5):1523-30. doi: 10.3892/ijo.2013.2097. Epub 2013 Sep 13.

PMID:
24042193
[PubMed - indexed for MEDLINE]
8.

A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.

Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, Tong DK, Law S, Chan KW, Ma S, Guan XY.

Cancer Res. 2013 Apr 1;73(7):2322-32. doi: 10.1158/0008-5472.CAN-12-2991. Epub 2013 Feb 4.

PMID:
23382045
[PubMed - indexed for MEDLINE]
Free Article
9.

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.

Kalinina T, Bockhorn M, Kaifi JT, Thieltges S, Güngör C, Effenberger KE, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki JR, Yekebas EF.

Int J Cancer. 2010 Oct 15;127(8):1931-40. doi: 10.1002/ijc.25196.

PMID:
20104520
[PubMed - indexed for MEDLINE]
10.

STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.

Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F, Ishii H, Okumura H, Natsugoe S, Mori M.

Ann Surg Oncol. 2011 Jan;18(1):261-72. doi: 10.1245/s10434-010-1271-1. Epub 2010 Aug 24.

PMID:
20734150
[PubMed - indexed for MEDLINE]
11.

Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.

Gong H, Song L, Lin C, Liu A, Lin X, Wu J, Li M, Li J.

Clin Cancer Res. 2013 Mar 1;19(5):1083-93. doi: 10.1158/1078-0432.CCR-12-3169. Epub 2013 Jan 14.

PMID:
23319823
[PubMed - indexed for MEDLINE]
Free Article
12.

Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.

Tian X, Ma P, Sui CG, Meng FD, Li Y, Fu LY, Jiang T, Wang Y, Jiang YH.

FEBS J. 2014 Jun;281(12):2805-19. doi: 10.1111/febs.12822. Epub 2014 May 21.

PMID:
24754231
[PubMed - indexed for MEDLINE]
13.

XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Shiozaki A, Kosuga T, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Iitaka D, Nakashima S, Shimizu H, Ishimoto T, Kitagawa M, Nakou Y, Kishimoto M, Liu M, Otsuji E.

Ann Surg Oncol. 2013 Sep;20(9):3140-50. doi: 10.1245/s10434-012-2474-4. Epub 2012 Jul 18.

PMID:
22805860
[PubMed - indexed for MEDLINE]
14.

Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.

Togashi Y, Arao T, Kato H, Matsumoto K, Terashima M, Hayashi H, de Velasco MA, Fujita Y, Kimura H, Yasuda T, Shiozaki H, Nishio K.

Oncotarget. 2014 May 30;5(10):2962-73.

PMID:
24930674
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.

Akagami M, Kawada K, Kubo H, Kawada M, Takahashi M, Kaganoi J, Kato S, Itami A, Shimada Y, Watanabe G, Sakai Y.

Ann Surg Oncol. 2011 Dec;18(13):3868-77. doi: 10.1245/s10434-011-1683-6. Epub 2011 Mar 31.

PMID:
21452064
[PubMed - indexed for MEDLINE]
16.

MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.

Hsu HS, Chen HW, Kao CL, Wu ML, Li AF, Cheng TH.

Ann Surg Oncol. 2011 May;18(5):1469-77. doi: 10.1245/s10434-010-1428-y. Epub 2010 Nov 13.

PMID:
21080085
[PubMed - indexed for MEDLINE]
17.

Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.

Hu M, Liu Q, Song P, Zhan X, Luo M, Liu C, Yang D, Cai Y, Zhang F, Jiang F, Zhang Y, Tang M, Zuo G, Zhou L, Luo J, Shi Q, Weng Y.

Oncol Rep. 2013 Jan;29(1):185-92. doi: 10.3892/or.2012.2117. Epub 2012 Oct 31.

PMID:
23128493
[PubMed - indexed for MEDLINE]
18.

Relationship between NRAGE and the radioresistance of esophageal carcinoma cell line TE13R120.

Xue XY, Liu ZH, Jing FM, Li YG, Liu HZ, Gao XS.

Chin J Cancer. 2010 Oct;29(10):900-6.

PMID:
20868560
[PubMed - indexed for MEDLINE]
Free Article
19.

Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo.

Ma J, Zhang J, Ma Y, Zheng J, Cheng Y, Xue Y, Liu W.

Med Oncol. 2012 Mar;29(1):119-26. doi: 10.1007/s12032-010-9774-y. Epub 2010 Dec 16.

PMID:
21161732
[PubMed - indexed for MEDLINE]
20.

Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH.

Ann Surg Oncol. 2012 Jan;19(1):326-35. doi: 10.1245/s10434-011-1867-0. Epub 2011 Jul 6.

PMID:
21732143
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk